Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
about
DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOsSynthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.Design, Synthesis, and Biological Evaluation of Novel 4-Aminopiperidinyl-linked 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs.Design, synthesis, and biological evaluation of novel 3,5-disubstituted-1,2,6-thiadiazine-1,1-dione derivatives as HIV-1 NNRTIs.Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.Synthesis and biological evaluation of novel 2-arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.Synthesis and biological evaluation of new conformationally restricted S-DABO hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
P2860
Q28535401-1D00E456-F48B-4D58-9AB4-C53A1F13AB9AQ34685500-653386F3-C298-4E88-AAD9-3047E6A4D031Q38915914-9EE36E48-C24A-46BB-A17E-3A624C546FA3Q38943621-1DDF2883-A412-4456-B3D2-A0F715B257C8Q39154248-38231605-CCA8-498B-A57A-E05A852CAC0FQ39507432-8E0FEE04-EF11-4491-855F-F75AB25AA507Q39591934-364A1B3D-5CE9-43E7-B6DF-6F981CB40927Q40566306-447ADC2E-A0F5-4202-97B8-E259E2F03E93Q42215254-648B5013-99B6-4C6E-9C8C-D6B8C3C4FC00Q57269187-3C870C54-1E24-4BFB-B444-6E1BCAD4D905
P2860
Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@ast
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@en
type
label
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@ast
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@en
prefLabel
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@ast
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants.
@en
P2093
P50
P356
P1476
Dihydro-alkylthio-benzyl-oxopy ...... and relevant clinical mutants
@en
P2093
Alberta Samuele
Andrea Tafi
Andrea Togninelli
Antonella Brizzi
Cesare Bernardini
Claudia Mugnaini
Federico Corelli
Giovanni Maga
Harsukh Gevariya
Imma Clotet-Codina
P304
P356
10.1021/JM0708230
P407
P577
2007-12-06T00:00:00Z